Randomized assessment of rapid endovascular treatment of ischemic stroke.
By M. Goyal, A. Demchuk, B. Menon, M. Eesa, J. Rempel, J. Thornton, D. Roy, T. Jovin, Robert A. Willinsky, B. Sapkota and 34 more. New England Journal of Medicine, 2015
5,324 citations recorded by the source corpus.
Subfields: Epidemiology, Pulmonary and Respiratory Medicine, Rehabilitation
View Paper: https://www.semanticscholar.org/paper/bf49253b67cbb334910918d55ebc721d6d1f8a93
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
Citations in the corpus
- Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024, background): “28 Observed reductions in DALYs were also probably driven by global vaccination and disease-prevention efforts, especially for Rates are provided to one decimal place.”
- Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. (2016, methodology): “16 Efficacy outcomes analyzed at 3 months were (1) degree of disability, assessed across 6 levels of the modified Rankin Scale (mRS), with ranks 5 and 6 combined into a single worst outcome rank; (2) functional independence, defined as mRS scores of 0 through 2; and (3) excellent outcome, defined as”
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct (2018, background): “Symptomatic intracranial hemorrhage at 24 hr† 6 (6) 3 (3) 3 (−3 to 8) 2 (1 to 7)”
- Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke (2018, neutral): “As defined by individual studies, the incidences of SICH following endovascular revascularization range from 2% to 10% for combined intravenous and intraarterial thrombolytic trials (9,12,39,122) and from 1% to 8% for EVT trials (7,11,13,20,121).”